Ignite Creation Date:
2025-12-24 @ 6:37 PM
Ignite Modification Date:
2026-04-07 @ 12:35 AM
Study NCT ID:
NCT00135057
Status:
COMPLETED
Last Update Posted:
2011-01-11
First Post:
2005-08-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Insulin Glulisine in Adult Subjects With Type 2 Diabetes Receiving Insulin Glargine as Basal Insulin
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HMR1964A_3502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Study Director
Old Organization:
sanofi-aventis